Clinical Trial

Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)

Name: Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE) — clinical trial record (NCT07210515)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: CRPS-RISE

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

Phase 3 Trial of AMBTX-01 (neridronate) for Complex Regional Pain Syndrome Type 1

Protocol Amendment History 1 change

notable Trial sites expanded: 15 -> 18 locations 2026-07-11

Trial Details

NCT Number	NCT07210515
Lead Sponsor	Ambros Therapeutics, Inc.
Conditions	Complex Regional Pain Syndrome Type I
Enrollment	270 participants
Start Date	2026-04-14
Primary Completion	2027-12 (estimated)
Study Completion	2028-01 (estimated)
Updated on ClinicalTrials.gov	2026-08-14